Related Experiment Video
Updated: Oct 17, 2025
10:00
An Ultrahigh-throughput Microfluidic Platform for Single-cell Genome Sequencing
Published on: May 23, 2018
17.9K
Microfluidics applications for high-throughput single cell sequencing
Wen-Min Zhou1, Yan-Yan Yan2, Qiao-Ru Guo1
1Key Laboratory of Molecular Target & Clinical Pharmacology , The State & NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences & the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, 511436, People's Republic of China.
Journal of Nanobiotechnology
|October 12, 2021
Summary
Single cell sequencing, using microfluidic technologies, reveals cellular heterogeneity crucial for diagnosing diseases like cancer and immune disorders. This approach overcomes limitations of traditional gene profiling methods.
Area of Science:
- Biotechnology
- Genomics
- Cell Biology
Background:
- Cellular heterogeneity is key in disease development and diagnosis.
- Traditional gene profiling methods obscure individual cell differences.
- Single cell sequencing (SCS) offers insights into cellular heterogeneity and rare cell populations.
Purpose of the Study:
- To review microfluidic principles for single cell analysis.
- To introduce SCS processes and high-throughput technologies.
- To illustrate SCS applications in cancer and immune disease diagnosis.
Main Methods:
- Review of microfluidic technologies for single cell isolation and analysis.
- Discussion of various high-throughput single cell sequencing platforms.
- Overview of the single cell sequencing workflow.
Main Results:
- Microfluidics enables precise single cell manipulation and analysis.
- High-throughput SCS technologies offer different advantages and disadvantages.
- SCS is a powerful tool for identifying cellular differences.
Conclusions:
- Microfluidics combined with SCS is vital for understanding cellular heterogeneity.
- SCS applications are expanding in diagnosing complex diseases.
- This technology advances precision medicine for cancer and immune diseases.
